CNST insider filings
CONSTELLATION PHARMACEUTICALS INC — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-23. Screen CNST transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CNST between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CONSTELLATION PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-07-23 | 4/A | Hoerter Steven L. — Director | Disposition to issuer (D): 26,342 (derivative) | EDGAR |
| 2021-07-19 | 4 | Humphrey Jeffrey — Chief Medical Officer | Disposition to issuer (D): 133,000 (derivative) · Disposition to issuer (D): 35,055 (derivative) | EDGAR |
| 2021-07-19 | 4 | Valentine Karen — See Remarks | Disposition to issuer (D): 58,600 (derivative) · Disposition to issuer (D): 81,939 (derivative) · Disposition to issuer (D): 22,425 (derivative) · Disposition to issuer (D): 41,800 (derivative) | EDGAR |
| 2021-07-19 | 4 | Trehu Elizabeth — Director | Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative) | EDGAR |
| 2021-07-19 | 4 | Trojer Patrick — Chief Scientific Officer | Disposition to issuer (D): 72,050 (derivative) · Disposition to issuer (D): 22,708 (derivative) · Disposition to issuer (D): 78,000 (derivative) · Disposition to issuer (D): 43,387 (derivative) · Disposition to issuer (D): 850 (derivative) · Disposition to issuer (D): 33,330 (derivative) · +4 more | EDGAR |
| 2021-07-19 | 4 | Reeve Emma — Chief Financial Officer | Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 37,527 (derivative) · Disposition to issuer (D): 73,428 (derivative) · Disposition to issuer (D): 11,777 (derivative) · Disposition to issuer (D): 17,666 (derivative) · Disposition to issuer (D): 80,971 (derivative) · +1 more | EDGAR |
| 2021-07-19 | 4 | Raythatha Jigar — See Remarks, Director | Disposition to issuer (D): 14,961 · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 306,938 (derivative) · Disposition to issuer (D): 245,000 (derivative) · Disposition to issuer (D): 141,929 (derivative) · Disposition to issuer (D): 141,929 (derivative) · +2 more | EDGAR |
| 2021-07-19 | 4 | Hoerter Steven L. — Director | Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative) | EDGAR |
| 2021-07-19 | 4 | Braunstein Scott — Director | Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative) | EDGAR |
| 2021-07-19 | 4 | Audia James E — Director | Disposition to issuer (D): 25,434 · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 8,175 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 1,277 (derivative) · Disposition to issuer (D): 9,083 (derivative) · +5 more | EDGAR |
| 2021-07-19 | 4 | Levy Richard S — Director | Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) | EDGAR |
| 2021-07-19 | 4 | GOLDSMITH MARK A — Director | Disposition to issuer (D): 89,857 · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 6,825 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 12,446 (derivative) · Disposition to issuer (D): 9,083 (derivative) · +1 more | EDGAR |
| 2021-06-04 | 4 | Braunstein Scott — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Trehu Elizabeth — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Hoerter Steven L. — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Audia James E — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Levy Richard S — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | GOLDSMITH MARK A — Director | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | GOLDSMITH MARK A — Director | Option exercise (M): 14,987 @ $0 · Option exercise (M): 14,987 (derivative) @ $0 | EDGAR |
| 2021-02-23 | 4 | Reeve Emma — Chief Financial Officer | Option exercise (M): 4,010 @ $8.04 · Sale (S): 4,010 @ $37.71 · Option exercise (M): 6,260 @ $8.04 · Sale (S): 6,260 @ $37.60 · Option exercise (M): 4,010 (derivative) @ $0 · Option exercise (M): 6,260 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | Reeve Emma — Chief Financial Officer | Option exercise (M): 410 @ $8.04 · Sale (S): 410 @ $37.56 · Option exercise (M): 1,100 @ $8.04 · Sale (S): 1,100 @ $37.58 · Option exercise (M): 410 (derivative) @ $0 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | COLUMN GROUP L P — 10% owner COLUMN GROUP III, LP — 10% owner COLUMN GROUP III-A, LP — 10% owner COLUMN GROUP III GP, LP — 10% owner COLUMN GROUP GP, LP — 10% owner PONOI CAPITAL, LP — 10% owner Ponoi Management, LLC — 10% owner Ponoi Capital II, LP — 10% owner Ponoi II Management, LLC — 10% owner Kutzkey Tim — 10% owner | Sale (S): 10,000 @ $36.95 | EDGAR |
| 2021-02-19 | 4 | COLUMN GROUP L P — 10% owner GOEDDEL DAVID V — 10% owner Svennilson Peter — 10% owner | Sale (S): 10,000 @ $36.95 | EDGAR |
| 2021-02-18 | 4 | Humphrey Jeffrey — Chief Medical Officer | Grant/award (A): 35,055 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Raythatha Jigar — See Remarks, Director | Grant/award (A): 204,500 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Valentine Karen — See Remarks | Grant/award (A): 58,600 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Trojer Patrick — Chief Scientific Officer | Grant/award (A): 72,050 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Reeve Emma — Chief Financial Officer | Grant/award (A): 66,950 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Valentine Karen — See Remarks | Option exercise (M): 17,203 @ $11.50 · Sale (S): 8,773 @ $33.08 · Sale (S): 1,227 @ $33.69 · Sale (S): 7,203 @ $35.11 · Option exercise (M): 17,203 (derivative) @ $0 | EDGAR |
| 2020-12-28 | 4 | GOLDSMITH MARK A — Director, 10% owner | Sale (S): 4,020 @ $35.02 | EDGAR |
| 2020-12-22 | 4 | Reeve Emma — Chief Financial Officer | Option exercise (M): 1,178 @ $7.60 · Option exercise (M): 4,542 @ $6.61 · Sale (S): 5,720 @ $35.11 · Option exercise (M): 1,178 (derivative) @ $0 · Option exercise (M): 4,542 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | COLUMN GROUP L P — 10% owner COLUMN GROUP III, LP — 10% owner COLUMN GROUP III-A, LP — 10% owner COLUMN GROUP III GP, LP — 10% owner COLUMN GROUP GP, LP — 10% owner PONOI CAPITAL, LP — 10% owner Ponoi Management, LLC — 10% owner Ponoi Capital II, LP — 10% owner Ponoi II Management, LLC — 10% owner Kutzkey Tim — 10% owner | Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | COLUMN GROUP L P — 10% owner GOEDDEL DAVID V — 10% owner Svennilson Peter — 10% owner | Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0 | EDGAR |
Recent 8-K events — CONSTELLATION PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-07-15 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2020-12-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2020-11-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2020-11-09 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNST returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs